Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis

INTRODUCTION: Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). However, the cost of IVIg is high. Higher doses of IVIg are associated with a more insupportable financial burden to paediatric patients’ families and may produc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiangge, Zhang, Miaomiao, Zhang, Xiaohan, Zhao, Peidong, Zhai, Wensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314640/
https://www.ncbi.nlm.nih.gov/pubmed/37385744
http://dx.doi.org/10.1136/bmjopen-2023-071644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314640/
https://www.ncbi.nlm.nih.gov/pubmed/37385744
http://dx.doi.org/10.1136/bmjopen-2023-071644

Ejemplares similares